Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary

Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary

Rationale & Objective: Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population...

Full description

Bibliographic Details
Main Authors:	Borut Cizman, Helen T. Smith, Rodrigo Refoios Camejo, Linda Casillas, Harjeet Dhillon, Fan Mu, Eric Wu, Jipan Xie, Peter Zuckerman, Daniel Coyne
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Kidney Medicine
Subjects:	ESA hyporesponsiveness erythropoietin health care resource utilization hemodialysis USRDS Medicare anemia of chronic kidney disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S259005952030162X

Similar Items

Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality
by: Marisa Roldão, et al.
Published: (2022-03-01)

Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)

Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis
by: Shizuka Kobayashi, et al.
Published: (2022-12-01)

Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
by: Kosaku Nitta, et al.
Published: (2022-12-01)

Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
by: Henry H.L. Wu, et al.
Published: (2022-01-01)

Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?
by: Henry H. L. Wu, et al.
Published: (2022-08-01)

In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
by: Ylenia Ingrasciotta, et al.
Published: (2019-09-01)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
by: Tomoaki Takata, et al.
Published: (2021-04-01)

Hyporesponse to statin therapy among patients with acute coronary syndrome: prevalence, impact on the development of heart failure in a short-term follow-up
by: I. V. Druk, et al.
Published: (2022-11-01)

Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
by: Tilman B. Drüeke
Published: (2018-11-01)

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome
by: Huidong Guo, et al.
Published: (2022-04-01)

Therapeutic potential of hyporesponsive CD4+ T cells in autoimmunity
by: Jaxaira eMaggi, et al.
Published: (2015-09-01)

Single-Cell RNA Sequencing of Donor-Reactive T Cells Reveals Role of Apoptosis in Donor-Specific Hyporesponsiveness of Kidney Transplant Recipients
by: Amy C. J. van der List, et al.
Published: (2023-09-01)

Contribution of IL-17 in Steroid Hyporesponsiveness in Obese Asthmatics Through Dysregulation of Glucocorticoid Receptors α and β
by: Saba Al Heialy, et al.
Published: (2020-08-01)

QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance HemodialysisPlain Language Summary
by: Patrick H. Pun, et al.
Published: (2023-05-01)

Data concordance between ESRD Medical Evidence Report and Medicare claims: is there any improvement?
by: Yi Mu, et al.
Published: (2018-07-01)

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
by: Antonio Lacquaniti, et al.
Published: (2023-06-01)

Single-cell RNA-seq analysis and cell-cluster deconvolution of the human preovulatory follicular fluid cells provide insights into the pathophysiology of ovarian hyporesponse
by: Kristine Roos, et al.
Published: (2022-10-01)

Association of Angiotensin Converting Enzyme gene polymorphism in anemic patients with regular haemodialysis in Sohag University Hospital
by: Nagwa S. Ahmed, et al.
Published: (2022-07-01)

Erythropoietin Has Kidney Protective Efficacy beyond Stimulating Erythropoiesis
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2013-07-01)

Endothelial cell-derived SSAO can increase MLC20 phosphorylation in VSMCs
by: Zhang Yuxing, et al.
Published: (2021-10-01)

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate
by: Keitaro Yokoyama, et al.
Published: (2017-05-01)

Sex Differences in Kidney Transplantation: Austria and the United States, 1978–2018
by: Sebastian Hödlmoser, et al.
Published: (2022-01-01)

Targeting Stress Erythropoiesis Pathways in Cancer
by: Sanja Vignjević Petrinović, et al.
Published: (2022-05-01)

Pharmacodynamic effects of molidustat on erythropoiesis in healthy cats
by: Annette Boegel, et al.
Published: (2024-01-01)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
by: Borut Cizman, et al.
Published: (2018-07-01)

Czech Participation in INTEGRAL: 1996–2011
by: R. Hudec, et al.
Published: (2011-01-01)

Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization
by: Tomoyuki Kawano, et al.
Published: (2017-05-01)

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
by: Jay B. Wish
Published: (2020-09-01)

Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS)
by: Joseph J. DeFerio, et al.
Published: (2017-08-01)

Relations between Sensory Responsiveness and Features of Autism in Children
by: Jacob I. Feldman, et al.
Published: (2020-10-01)

Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial
by: Yuki Kawai, et al.
Published: (2021-04-01)

Enhancing Erythropoiesis by a Phytoestrogen Diarylheptanoid from <i>Curcuma comosa</i>
by: Kanit Bhukhai, et al.
Published: (2022-06-01)

Regulation of erythropoiesis: emerging concepts and therapeutic implications
by: Pu Tang, et al.
Published: (2023-12-01)

Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias
by: David J. Meyers, et al.
Published: (2021-01-01)

Statin use and hip fractures in U.S. kidney transplant recipients
by: Chandan Vangala, et al.
Published: (2017-05-01)

Incidência de episódios hipotônicos-hiporresponsivos associados à vacina combinada DTP/Hib usada no Programa Nacional de Imunizações Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program
by: Reinaldo M. Martins, et al.
Published: (2007-12-01)

Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
by: Tzu-Lin Chen, et al.
Published: (2018-05-01)

Functional requirements for a Samd14-capping protein complex in stress erythropoiesis
by: Suhita Ray, et al.
Published: (2022-06-01)

The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs
by: E.H. Fiocchi, et al.
Published: (2017-03-01)